Veravanti Inc Profile last edited on: 1/30/2018
CAGE: 7HFC1
UEI: QCKNV6BL8B23
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
2260 152nd Avenue Ne Suite 200
Redmond, WA 98052
Redmond, WA 98052
| (425) 201-6070 |
| info@veravanti.com |
| www.veravanti.com |
Location: Single
Congr. District: 01
County: King
Congr. District: 01
County: King
Public Profile
VerAvanti Inc. is a medical device company working on development of an optical imaging technology that, when productized, could offers the potential for interventional cardiologists to reduce sight line gaps that are critical to proactively diagnosing and treating individuals at-risk for stroke and cardiovascular events. With the objectives of improving clinical outcome and lowering the overall cost of healthcare, the patented medical device is called a Scanning Fiber Endoscope.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
15-19Revenue Range
1.5M-2MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2022 | 2 | NIH | $1,995,369 | |
| Project Title: Endoscope development for the clinical use of near infrared fluorescence molecular probes in the GI tract | ||||
| 2017 | 1 | NIH | $286,069 | |
| Project Title: Optical visualization to efficiently guide coronary intervention of chronic total occlusions. | ||||
| 2017 | 1 | NIH | $300,000 | |
| Project Title: 4-Channel Multimodal Ultrathin-Flexible SFE for cancer diagnosis and therapy | ||||
| 0 | 1 | NIH | $309,428 | |
| Project Title: Development of Quantitative In Vivo Imaging of Oral Biofilm pH to Allow Prevention of Enamel Demineralization | ||||
Key People / Management
Russell A Garrison -- President, COO & Director
Gerald McMorrow -- CEO and Founder
Andrea Chen -- Vice President of Mems
Mark Kenned -- Executive Vice President of Us Sales
David L Odom -- CFO & Consultant
Gerald McMorrow -- CEO and Founder
Andrea Chen -- Vice President of Mems
Mark Kenned -- Executive Vice President of Us Sales
David L Odom -- CFO & Consultant
